- Home
- ACHV vs LTRX Comparison
ACHV vs LTRX Comparison
Compare ACHV & LTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- LTRX
- Stock Information
- Founded
- ACHV N/A
- LTRX 1989
- Country
- ACHV Canada
- LTRX United States
- Employees
- ACHV N/A
- LTRX N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- LTRX Computer Communications Equipment
- Sector
- ACHV Health Care
- LTRX Telecommunications
- Exchange
- ACHV Nasdaq
- LTRX Nasdaq
- Market Cap
- ACHV 72.5M
- LTRX 85.6M
- IPO Year
- ACHV N/A
- LTRX 2000
- Fundamental
- Price
- ACHV $3.35
- LTRX $2.52
- Analyst Decision
- ACHV Strong Buy
- LTRX Strong Buy
- Analyst Count
- ACHV 3
- LTRX 5
- Target Price
- ACHV $14.33
- LTRX $5.10
- AVG Volume (30 Days)
- ACHV 325.9K
- LTRX 266.0K
- Earning Date
- ACHV 08-12-2025
- LTRX 05-08-2025
- Dividend Yield
- ACHV N/A
- LTRX N/A
- EPS Growth
- ACHV N/A
- LTRX N/A
- EPS
- ACHV N/A
- LTRX N/A
- Revenue
- ACHV N/A
- LTRX $143,159,000.00
- Revenue This Year
- ACHV N/A
- LTRX N/A
- Revenue Next Year
- ACHV N/A
- LTRX $3.61
- P/E Ratio
- ACHV N/A
- LTRX N/A
- Revenue Growth
- ACHV N/A
- LTRX N/A
- 52 Week Low
- ACHV $1.84
- LTRX $1.91
- 52 Week High
- ACHV $5.31
- LTRX $4.55
- Technical
- Relative Strength Index (RSI)
- ACHV 52.46
- LTRX 60.21
- Support Level
- ACHV $3.44
- LTRX $2.28
- Resistance Level
- ACHV $3.91
- LTRX $2.62
- Average True Range (ATR)
- ACHV 0.30
- LTRX 0.13
- MACD
- ACHV -0.09
- LTRX 0.02
- Stochastic Oscillator
- ACHV 28.03
- LTRX 80.00
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About LTRX Lantronix Inc.
Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.